Quick Answer
Cardlytics, Inc. reported Research And Development Expense of $39.77 million for the year ending 2025.
- Cardlytics, Inc. showed a decrease of -19.8% in Research And Development Expense from 2024 to 2025.
- This data is from Cardlytics, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Cardlytics, Inc.'s Research And Development Expense has grown by 186.0%.
- Historical annual values: Fiscal year 2025: $39.77 million | Fiscal year 2024: $49.61 million | Fiscal year 2023: $51.35 million | Fiscal year 2022: $54.44 million | Fiscal year 2021: $38.10 million | Fiscal year 2020: $17.53 million | Fiscal year 2019: $11.70 million | Fiscal year 2018: $16.21 million | Fiscal year 2017: $12.15 million | Fiscal year 2016: $13.90 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: